BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 541407)

  • 1. Simultaneous gas chromatographic determination of lorcainide hydrochloride and three of its principal metabolites in biological samples.
    Woestenborghs R; Michiels M; Heykants J
    J Chromatogr; 1979 Oct; 164(2):169-76. PubMed ID: 541407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass spectral investigation of the metabolites of lorcainide in man.
    Lauwers WF; Meuldermans WE; Bracke JO
    Eur J Drug Metab Pharmacokinet; 1983; 8(4):351-62. PubMed ID: 6673972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use and limitations of deuterated lorcainide in metabolism and pharmacokinetic studies.
    Gelijkens CF; Van Peer A; Lenoir H; Knaeps A; Woestenborghs R; Heykants J
    Biomed Mass Spectrom; 1985 Jan; 12(1):38-42. PubMed ID: 3157409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics and tissue distribution of the new antiarrhythmic agent lorcainide (R 15889) in rats.
    Klotz U; Golbs E
    Arzneimittelforschung; 1980; 30(4):619-21. PubMed ID: 7190402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excretion and metabolism of lorcainide in rats, dogs and man.
    Meuldermans W; Hurkmans R; Swysen E; Hendrickx J; Thijssen J; Lauwers W; Heykants J
    Eur J Drug Metab Pharmacokinet; 1983; 8(4):335-49. PubMed ID: 6673971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HPLC method for determination of lorcainide hydrochloride in human serum].
    Luo X; Zeng FD
    Yao Xue Xue Bao; 1995; 30(8):605-9. PubMed ID: 8571780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitive gas chromatographic method for the determination of cinnarizine and flunarizine in biological samples.
    Woestenborghs R; Michielsen L; Lorreyne W; Heykants J
    J Chromatogr; 1982 Oct; 232(1):85-91. PubMed ID: 7142341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitation of flecainide acetate, a new antiarrhythmic agent, in biological fluids by gas chromatography with electron-capture detection.
    Johnson JD; Carlson GL; Fox JM; Miller AM; Chang SF; Conrad GJ
    J Pharm Sci; 1984 Oct; 73(10):1469-71. PubMed ID: 6502499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamics of the initiation of antiarrhythmic therapy with lorcainide.
    Winkle RA; Keefe DL; Rodriguez I; Kates RE
    Am J Cardiol; 1984 Feb; 53(4):544-51. PubMed ID: 6198895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of lorcainide, a new antiarrhythmic drug, in patients with cardiac rhythm disorders.
    Somani P
    Am J Cardiol; 1981 Jul; 48(1):157-63. PubMed ID: 7246437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of flecainide and lorcainide in blood by means of TLC.
    Paw B; Przyborowski L
    Acta Pol Pharm; 1995; 52(1):5-7. PubMed ID: 8960234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of levamisole in plasma and animal tissues by gas chromatography with thermionic specific detection.
    Woestenborghs R; Michielsen L; Heykants J
    J Chromatogr; 1981 Jun; 224(1):25-32. PubMed ID: 7263817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of lorcainide.
    Keefe DL
    Am J Cardiol; 1984 Aug; 54(4):18B-21B. PubMed ID: 6465043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolites of cardiac antiarrhythmic drugs: their clinical role.
    Kates RE
    Ann N Y Acad Sci; 1984; 432():75-89. PubMed ID: 6441496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of lorcainide in man: a new antiarrhythmic agent.
    Klotz U; Müller-Seydlitz P; Heimburg P
    Clin Pharmacokinet; 1978; 3(5):407-18. PubMed ID: 699462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics of the newer antiarrhythmic agents.
    Gillis AM; Kates RE
    Clin Pharmacokinet; 1984; 9(5):375-403. PubMed ID: 6437721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electron-capture GLC determination of a new antiarrhythmic agent, alpha,alpha-dimethyl-4-(alpha,alpha,beta,beta-tetrafluorophenethyl) benzylamine, in biological fluids.
    Zacchei AG; Weidner L
    J Pharm Sci; 1975 May; 64(5):814-8. PubMed ID: 1151652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lorcainide kinetics and protein binding in patients with end-stage renal disease.
    Somani P; Simon V; Gupta RK; King P; Shapiro RS; Stockard H
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):121-5. PubMed ID: 6715079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic effect of lorcainide during chronic treatment.
    Meinertz T; Kasper W; Kersting F; Bechtold H; Just H; Jähnchen E
    Arzneimittelforschung; 1980; 30(9):1593-5. PubMed ID: 7193031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of enzyme induction on the disposition of lorcainide in rats following intravenous and oral administration.
    Plänitz V; Jähnchen E
    Arzneimittelforschung; 1984; 34(6):669-71. PubMed ID: 6541487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.